{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:49:28Z","timestamp":1790714968610,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.rmed.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T06:59:00Z","timestamp":1410850740000},"page":"1397-1408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Long-term macrolide maintenance therapy in non-CF bronchiectasis: Evidence and questions"],"prefix":"10.1016","volume":"108","author":[{"given":"Charles S.","family":"Haworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Stuart","family":"Elborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmed.2014.09.005_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4997\/JRCPE.2011.217","article-title":"Non-cystic fibrosis bronchiectasis","volume":"41","author":"Smith","year":"2011","journal-title":"J R Coll Physicians Edinb"},{"issue":"4 pt 1","key":"10.1016\/j.rmed.2014.09.005_bib2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"Pasteur","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rmed.2014.09.005_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.rmed.2006.11.008","article-title":"Aetiology in adult patients with bronchiectasis","volume":"101","author":"Shoemark","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2014.09.005_bib4","unstructured":"European Respiratory Society. European White Lung Book. http:\/\/www.erswhitebook.org\/ [accessed 01.11.13]."},{"issue":"2","key":"10.1016\/j.rmed.2014.09.005_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.prrv.2010.10.010","article-title":"Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries","volume":"12","author":"Kapur","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"6","key":"10.1016\/j.rmed.2014.09.005_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 1","key":"10.1016\/j.rmed.2014.09.005_bib7","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.rmed.2014.09.005_bib8","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"The lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.rmed.2014.09.005_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2014.09.005_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1183\/09031936.00052712","article-title":"A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis","volume":"41","author":"Duff","year":"2013","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.rmed.2014.09.005_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","article-title":"Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition","volume":"68","author":"Rogers","year":"2013","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2014.09.005_bib12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2014.09.005_bib13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.rmed.2014.09.005_bib14","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis","volume":"102","author":"Anwar","year":"2008","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2014.09.005_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1753465811406771","article-title":"Neomacrolides in the treatment of patients with severe asthma and\/or bronchiectasis: a retrospective observational study","volume":"5","author":"Coeman","year":"2011","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"10.1016\/j.rmed.2014.09.005_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2014.09.005_bib17","first-page":"540","article-title":"Prophylactic antibiotic treatment of bronchiectasis with azithromycin","volume":"59","author":"Davies","year":"2004","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2014.09.005_bib18","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rmed.2014.09.005_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.rmed.2011.01.009","article-title":"Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations","volume":"105","author":"Serisier","year":"2011","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.rmed.2014.09.005_bib20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.rmed.2014.09.005_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"Eur Respir J"},{"issue":"9842","key":"10.1016\/j.rmed.2014.09.005_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rmed.2014.09.005_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yal\u00e7in","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.rmed.2014.09.005_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/134605","article-title":"The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis","volume":"134605","author":"Masekela","year":"2012","journal-title":"Mediat Inflamm"},{"issue":"3","key":"10.1016\/j.rmed.2014.09.005_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharmthera.2007.11.001","article-title":"Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action","volume":"117","author":"Shinkai","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.rmed.2014.09.005_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00228-011-1161-x","article-title":"Macrolides: from in\u00a0vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases","volume":"68","author":"Zarogoulidis","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.rmed.2014.09.005_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000320320","article-title":"Immunomodulatory effects of macrolide antibiotics \u2013 part 2: advantages and disadvantages of long-term, low-dose macrolide therapy","volume":"81","author":"Altenburg","year":"2011","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2014.09.005_bib28","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.rmed.2014.09.005_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2014.09.005_bib30","first-page":"CD007716","article-title":"Macrolides for diffuse panbronchiolitis","author":"Yang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2 pt 1","key":"10.1016\/j.rmed.2014.09.005_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George's Respiratory Questionnaire in bronchiectasis","volume":"156","author":"Wilson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.rmed.2014.09.005_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"issue":"13","key":"10.1016\/j.rmed.2014.09.005_bib33","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.rmed.2014.09.005_bib34","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.200502-218OC","article-title":"Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis","volume":"172","author":"Saiman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"10.1016\/j.rmed.2014.09.005_bib35","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.rmed.2014.09.005_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2012.05.010","article-title":"A retrospective analysis of the impact of azithromycin maintenance therapy on adults attending a UK cystic fibrosis clinic","volume":"12","author":"Fleet","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.rmed.2014.09.005_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":"Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function","volume":"26","author":"Tramper-Stranders","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"9842","key":"10.1016\/j.rmed.2014.09.005_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(12)61261-6","article-title":"Azithromycin in bronchiectasis: when should it be used?","volume":"380","author":"Wilson","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.rmed.2014.09.005_bib39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.2013.2780","article-title":"Macrolides and bronchiectasis: clinical benefit with a resistance price","volume":"309","author":"Elborn","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.rmed.2014.09.005_bib40","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2014.09.005_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clin Pulm Med"},{"issue":"1","key":"10.1016\/j.rmed.2014.09.005_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1378\/chest.09-2932","article-title":"Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?","volume":"138","author":"Kapur","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2014.09.005_bib43","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2014.09.005_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1378\/chest.128.2.739","article-title":"Quality-of-life determinants in patients with clinically stable bronchiectasis","volume":"128","author":"Mart\u00ednez-Garc\u00eda","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2014.09.005_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00160508","article-title":"Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2009","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rmed.2014.09.005_bib46","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmed.2014.09.005_bib47","doi-asserted-by":"crossref","first-page":"A453","DOI":"10.1378\/chest.1117441","article-title":"Content validation of a disease-specific patient-reported outcome for bronchiectasis [abstract]","volume":"140","author":"Quittner","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2014.09.005_bib48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1183\/09031936.00122508","article-title":"Assessing response to treatment of exacerbations of bronchiectasis in adults","volume":"33","author":"Murray","year":"2009","journal-title":"Eur Respir J"},{"issue":"20","key":"10.1016\/j.rmed.2014.09.005_bib49","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.rmed.2014.09.005_bib50","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1172\/JCI46095","article-title":"Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection","volume":"121","author":"Renna","year":"2011","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.rmed.2014.09.005_bib51","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/rccm.201307-1200OC","article-title":"Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis","volume":"188","author":"Binder","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rmed.2014.09.005_bib52","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1183\/09031936.00065612","article-title":"Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients","volume":"41","author":"Catherinot","year":"2013","journal-title":"Eur Respir J"},{"issue":"9560","key":"10.1016\/j.rmed.2014.09.005_bib53","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2014.09.005_bib54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jac\/dkm235","article-title":"Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts?","volume":"60","author":"Tramper-Stranders","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmed.2014.09.005_bib55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway disease","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2014.09.005_bib56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2431-12-122","article-title":"Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial","volume":"12","author":"Valery","year":"2012","journal-title":"BMC Pediatr"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114003163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114003163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:30:54Z","timestamp":1760614254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611114003163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0954611114003163"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2014.09.005","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term macrolide maintenance therapy in non-CF bronchiectasis: Evidence and questions","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}